Sara Costa

Sara Costa

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
LPLucas Possebon
Lucas Possebon
ILIsabella de Souza Lima Lebron
Isabella de Souza Lima Lebron
LSLigia Furlan da Silva
Ligia Furlan da Silva
JPJulia Tagliaferri Paletta
Julia Tagliaferri Paletta
BGBruna Gabrieli Glad
Bruna Gabrieli Glad
Ana Paula GirolAna Paula Girol
Ana Paula Girol

9 March 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HSHelena Ribeiro Souza
Helena Ribeiro Souza
LALucas Ribeiro de Azevedo
Lucas Ribeiro de Azevedo
LPLucas Possebon
Lucas Possebon
SCSara Costa
Sara Costa
MIMelina Mizusaki Iyomasa-Pilon
Melina Mizusaki Iyomasa-Pilon
Ana Paula GirolAna Paula Girol
Ana Paula Girol
Mast cells (MCs) participate in all stages of skin healing and one of their mediators is the Annexin A1 protein (AnxA1), linked to inflammation, proliferation, migration and apoptosis processes, but not studied in thermal burns yet. Therefore, our objectives were to evaluate the behavior of MCs and AnxA1 in a second degree burn model, treated or not with silver sulfadiazine 1% (SDP 1%) and associated to macrophages quantification and cytokines dosages. MCs counts showed few cells in the early stages of repair but increased MCs in the final phases in the untreated group. The normal skin presented numerous tryptase-positive MCs that were reduced after burning in all analyzed periods. Differently, few chymase-positive MCs were observed in the early stages of healing, however, increased chymase-positive MCs were found at the final phase in the untreated group. MCs also showed high immunoreactivity for AnxA1 on day 3 in both groups. In the tissue there was a strong protein expression in the early stages of healing, but in the final phases only in the SDP treated animals. TNF-α, IL-1β, IL-6, IL-10 and MCP-1 levels and macrophages quantification were increased in inflammation and reepithelialization phases. Reduced IL-1β, IL-6 and IL-10 levels and numerous macrophages occurred in the treated animals during tissue repair. Our results indicate modulation in the profile of MCs and AnxA1expression during healing by the treatment with SDP 1%, pointing them as targets for therapeutic interventions on skin burns.

1 October 2018 in International Immunopharmacology
Verified
Journal Article
Closed access
LPLucas Possebon
Lucas Possebon
SCSara Costa
Sara Costa
HSHelena R. Souza
Helena R. Souza
LALucas R. Azevedo
Lucas R. Azevedo
MSMonielle Sant'ANa
Monielle Sant'ANa
Ana Paula GirolAna Paula Girol
Ana Paula Girol

1 February 2018 in Pathology - Research and Practice
Verified
Journal Article
Closed access
RTRodolfo T.C. Takaoka
Rodolfo T.C. Takaoka
NSNathália D. Sertório
Nathália D. Sertório
LMLara P.J. Magalini
Lara P.J. Magalini
LSLeandro M. Dos Santos
Leandro M. Dos Santos
HSHelena R. Souza
Helena R. Souza
Ana Paula GirolAna Paula Girol
Ana Paula Girol

15 November 2021 in Cells
Verified
Journal Article
Open access
PDF file
Ana Paula GirolAna Paula Girol
Ana Paula Girol
CZCaroline de Freitas Zanon
Caroline de Freitas Zanon
ICIcaro Caruso
Icaro Caruso
SCSara Costa
Sara Costa
HSHelena Ribeiro Souza
Helena Ribeiro Souza
SOSonia Maria Oliani
Sonia Maria Oliani
Uveitis is one of the main causes of blindness worldwide, and therapeutic alternatives are worthy of study. We investigated the effects of piperlongumine (PL) and/or annexin A1 (AnxA1) mimetic peptide Ac2-26 on endotoxin-induced uveitis (EIU). Rats were inoculated with lipopolysaccharide (LPS) and intraperitoneally treated with Ac2-26 (200 µg), PL (200 and 400 µg), or Ac2-26 + PL after 15 min. Then, 24 h after LPS inoculation, leukocytes in aqueous humor, mononuclear cells, AnxA1, formyl peptide receptor (fpr)1, fpr2, and cyclooxygenase (COX)-2 were evaluated in the ocular tissues, along with inflammatory mediators in the blood and macerated supernatant. Decreased leukocyte influx, levels of inflammatory mediators, and COX-2 expression confirmed the anti-inflammatory actions of the peptide and pointed to the protective effects of PL at higher dosage. However, when PL and Ac2-26 were administered in combination, the inflammatory potential was lost. AnxA1 expression was elevated among groups treated with PL or Ac2-26 + PL but reduced after treatment with Ac2-26. Fpr2 expression was increased only in untreated EIU and Ac2-26 groups. The interaction between Ac2-26 and PL negatively affected the anti-inflammatory action of Ac2-26 or PL. We emphasize that the anti-inflammatory effects of PL can be used as a therapeutic strategy to protect against uveitis.

1 December 2018 in Annals of Diagnostic Pathology
Verified
Journal Article
Closed access
MTMaryam Buainain Tadei
Maryam Buainain Tadei
MMMatheus Vicente Mayorquim
Matheus Vicente Mayorquim
CSCamila Brambilla de Souza
Camila Brambilla de Souza
SCSara Costa
Sara Costa
LPLucas Possebon
Lucas Possebon
Ana Paula GirolAna Paula Girol
Ana Paula Girol